On Monday (local time), U.S. President Donald Trump announced a 100% tariff on all films produced outside the United States, stating that the country’s film industry has been “stolen” by foreign nations.
In a post on Truth Social, Trump wrote:
“Our movie-making business has been stolen from the United States of America by other countries—just like stealing candy from a baby. California, with its weak and incompetent Governor, has been particularly hard hit!”
To address what he called a “long-time, never-ending problem,” Trump declared:
“I will be imposing a 100% Tariff on any and all movies made outside of the United States. Thank you for your attention to this matter. MAKE AMERICA GREAT AGAIN! — President DJT”
This latest announcement follows Trump’s September 26 declaration that his administration would impose a 100% tariff on branded and patented pharmaceutical products starting October 1, 2025, unless the companies move their production to U.S. soil.
India, a major player in the global pharmaceutical supply chain, could be significantly impacted. The country supplies over 50% of the global demand for vaccines, 40% of generic drugs used in the U.S., and 25% of all medicines consumed in the UK.
India’s pharmaceutical exports reached a record USD 30 billion in FY25, driven by a sharp 31% year-on-year increase in March. According to government data, exports of drugs and pharmaceuticals grew by 6.94%, rising from USD 2.35 billion in August 2024 to USD 2.51 billion in August 2025.
In FY24, India exported USD 27.9 billion worth of pharmaceuticals, with the U.S. accounting for approximately 31% (USD 8.7 billion or Rs 77,231 crore). In just the first half of 2025, India exported USD 3.7 billion (approx. Rs 32,505 crore) worth of pharmaceutical products worldwide, as per data from the Pharmaceuticals Export Promotion Council of India (Pharmexcil).
Leading companies such as Dr. Reddy’s, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma and Gland Pharma derive between 30-50 per cent of their overall revenues from the American market.
According to a separate government report, India’s pharmaceutical industry is a global powerhouse, ranking third in the world by volume and 14th in terms of production value. It supplies over 50 per cent of global vaccine demand and nearly 40 per cent of generics to the US. The industry is projected to grow to USD 130 billion by 2030 and a USD 450 billion market by 2047.
Backed by policy support for pharmaceuticals, such as the PLI scheme (Rs. 15,000 crore) and the Strengthening of Pharmaceuticals Industry (SPI) scheme (Rs. 500 crore), the industry continues to expand its global footprint.
The PLI scheme is driving investments into 55 projects to manufacture high-end drugs, such as those for cancer and diabetes, in India. Meanwhile, the SPI scheme, which focuses on enhancing the quality, competitiveness, and resilience of smaller pharmaceutical companies, is funding R&D and modernising labs, enabling Indian companies to compete globally. Beyond cost efficiency, India has emerged as a hub for affordable, high-quality medicines, reinforcing its rightful title as the “Pharmacy of the World,” the report said.
Earlier, in a post on Truth Social, US President Trump wrote, “Starting October 1st, 2025, we will be imposing a 100 per cent Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. ‘IS BUILDING’ will be defined as ‘breaking ground’ and/or ‘under construction.'”
Clarifying the scope of the measure, Trump added that companies that have already begun construction of plants in the US will be exempt from the new tariff. “There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started. Thank you for your attention to this matter!” the post read.
He also announced sweeping tariffs on various household products, including imported kitchen cabinets and certain types of furniture, which could add even more costs to a category that has surged in price in recent months. Trump also announced heavy tariffs on trucks and pharmaceuticals.
Trump wrote in a Truth Social post, “We will be imposing a 50 per cent Tariff on all Kitchen Cabinets, Bathroom Vanities, and associated products, starting October 1st, 2025. Additionally, we will be charging a 30 per cent Tariff on Upholstered Furniture.- With Inputs From ANI.
Also Read: Pakistani Security Forces Open Fire On Protesters In PoK, 1 Dead, Several Injured
